일본 - 영어 - すりの適正使用協議会 RAD-AR Council, Japan

kyowa kirin co.,ltd - filgrastim(genetical recombination) - injection

일본 - 영어 - すりの適正使用協議会 RAD-AR Council, Japan

kyowa kirin co.,ltd - filgrastim(genetical recombination) - injection

일본 - 영어 - すりの適正使用協議会 RAD-AR Council, Japan

kyowa kirin co.,ltd - filgrastim(genetical recombination) - injection

일본 - 영어 - すりの適正使用協議会 RAD-AR Council, Japan

kyowa kirin co.,ltd - filgrastim(genetical recombination) - injection

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

recordati rare diseases australia pty ltd - siltuximab, quantity: 400 mg - injection, powder for - excipient ingredients: polysorbate 80; sucrose; histidine - sylvant is indicated for the treatment of patients with multicentric castleman's disease (mcd) who are human immunodeficiency virus (hiv) negative and human herpesvirus-8 (hhv-8) negative.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

recordati rare diseases australia pty ltd - siltuximab, quantity: 100 mg - injection, powder for - excipient ingredients: histidine; polysorbate 80; sucrose - sylvant is indicated for the treatment of patients with multicentric castleman's disease (mcd) who are human immunodeficiency virus (hiv) negative and human herpesvirus-8 (hhv-8) negative.

이스라엘 - 영어 - Ministry of Health

roche pharmaceuticals (israel) ltd - rituximab - concentrate for solution for infusion - rituximab 10 mg/ml - rituximab - rituximab - mabthera is indicated for the following indications: * non-hodgkin’s lymphoma (nhl)mabthera is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, b-cell non-hodgkin’s lymphoma.mabthera is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy mabthera is indicated for the treatment of patients with cd20 positive diffuse large b-cell non-hodgkin's lymphoma in combination with chop chemotherapy. mabthera maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy. * chronic lymphocytic leukaemia (cll)mabthera in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including mabthera or patients refractory to previous mabthera plus chemotherapy.* rheumatoid arthritismabthera is indicated, in combination with methotrexate, to reduce signs and symptoms in adult patients with moderately to severely active rheumatoid arthritis who had an inadequate response or intolerance to one or more tnf antagonist therapies.* granulomatosis with polyangiitis and microscopic polyangiitismabthera, in combination with glucocorticoids, is indicated for the treatment of adult patients with granulomatosis with polyangiitis (gpa) (wegener’s granulomatosis (wg) and microscopic polyangiitis (mpa). *pemphigus vulgarismabthera is indicated for the treatment of adult patients with moderate to severe pemphigus vulgaris (pv).

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - rituximab, quantity: 1600 mg - injection - excipient ingredients: vorhyaluronidase alfa; histidine; histidine hydrochloride; trehalose dihydrate; methionine; polysorbate 80; water for injections - mabthera sc 1600 mg is indicated for the treatment of patients with cd20 positive chronic lymphocytic leukaemia (cll) in combination with chemotherapy.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - rituximab, quantity: 1400 mg - injection - excipient ingredients: vorhyaluronidase alfa; histidine; histidine hydrochloride; trehalose dihydrate; methionine; polysorbate 80; water for injections - mabthera sc is indicated for treatment of patients with: - cd20 positive, previously untreated, stage iii/iv follicular, b-cell non-hodgkin's lymphoma, - cd20 positive, relapsed or refractory low grade or follicular, b-cell non-hodgkin's lymphoma, - cd 20 positive, diffuse large b-cell non-hodgkin's lymphoma, in combination with chemotherapy.

케냐 - 영어 - Pharmacy and Poisons Board

amring farma s.r.l. blvd. mircea eliade 7, sector 1, bucuresti, - rituximab - concentrate for solution for infusion - 10mg/ml - rituximab